Change needed in pharmaco-payer relationship; Cancer spending slowing (PRVR–5/19 – 5/23/14)

This week on Pharma Research VIDEO Report:  1) Ernst & Young’s annual global pharmaceutical industry report is chock-full of insights about the critical business relationship between pharmaceutical companies and payers that needs substantial repair.    2)  An IMS Institute for Healthcare Informatics shows that the impressive $91 billion invested worldwide — annually — in oncology medicines has been significantly slowing. 3) A Mobiquity survey, conduct by Research Now, reveals 55% of health & fitness app users plan to buy wearable devices to track and improve their health because  they believe they are physically benefitting.

We want to hear from you

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,705 other followers

%d bloggers like this: